Adrenal insufficiency and response to corticosteroids in hypotensive critically ill children with cancer

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 480-487

  Hebbar, Kiran B ^a   Petrillo, Toni ^a   Fortenberry, James D ^a  

^a Children's Healthcare of Atlanta at Egleston   (United States)

Author keywords

Adrenal insufficiency; Cortisol; Hypotension; Oncology; Pediatric

Indexed keywords

CORTICOSTEROID; DOPAMINE; FLUDROCORTISONE; HYDROCORTISONE; NORADRENALIN; TETRACOSACTIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CORTICOTROPIN TEST; CRITICALLY ILL PATIENT; FLUID RESUSCITATION; HEMATOLOGIC MALIGNANCY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; LOW DRUG DOSE; LYMPHOMA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPTIC SHOCK; SOLID TUMOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; HUMANS; HYDROCORTISONE; HYPOTENSION; INFANT; NEOPLASMS; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASOCONSTRICTOR AGENTS;

EID: 84867333251     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.03.013     Document Type: Article

References (29)

1. Patterson B.C., Truxillo L., Wasilewski-Masker K., et al. Adrenal function testing in pediatric cancer survivors. Pediatr Blood Cancer 2009, 53:1302-1307.
2. Einaudi S., Bertorello N., Masera N., et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008, 50:537-541.
3. Hebbar KB, Stockwell JA, Leong T, et al. Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor-dependent shock. Crit Care Med 39(5):1145-50.
4. Brierley J., Carcillo J.A., Choong K., et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009, 37:666-688.
5. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
6. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
7. Pediatric dosage handbook 1999, 2000. Lexi-Comp Inc, Cleveland. 6th ed. C.K. Taketomo, J.H. Hodding, D.M. Kraus (Eds.).
8. Preissig C.M., Hansen I., Roerig P.L., et al. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit. Pediatr Crit Care Med 2008, 9:581-588.
9. Sarthi M., Lodha R., Vivekanandhan S., et al. Adrenal status in children with septic shock using low-dose stimulation test. Pediatr Crit Care Med 2007, 8:23-28.
10. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
11. Gonzalez H, Nardi O, Annane D. Relative adrenal failure in the ICU: an identifiable problem requiring treatment. Crit Care Clin 2006;22:105-118, vii.
12. Leteurtre S., Martinot A., Duhamel A., et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003, 362:192-197.
13. Leteurtre S., Duhamel A., Grandbastien B., et al. Paediatric logistic organ dysfunction (PELOD) score. Lancet 2006, 367:897. [author reply 900-892].
14. Bilan N., Galehgolab B.A., Emadaddin A., et al. Risk of mortality in pediatric intensive care unit, assessed by PRISM-III. Pak J Biol Sci 2009, 12:480-485.
15. Pollack M.M., Patel K.M., Ruttimann U.E. PRISM III: an updated Pediatric Risk Of Mortality score. Crit Care Med 1996, 24:743-752.
16. Gapany C, Tercier S, Diezi M, et al. Frequent accesses to totally implanted vascular ports in pediatric oncology patients are associated with higher infection rates. J Vasc Access.
17. Felner E.I., Thompson M.T., Ratliff A.F., et al. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr 2000, 137:21-24.
18. Marik P.E. Critical illness-related corticosteroid insufficiency. Chest 2009, 135:181-193.
19. Hew M., Bhavsar P., Torrego A., et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174:134-141.
20. Meduri G.U., Muthiah M.P., Carratu P., et al. Nuclear factor-kappaB- and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005, 12:321-338.
21. Chikanza I.C., Kozaci D., Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J Endocrinol 2003, 179:301-310.
22. Zimmerman J.J. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med 2007, 8:530-539.
23. Stark A.R., Carlo W.A., Tyson J.E., et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001, 344:95-101.
24. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
25. Finfer S. Corticosteroids in septic shock. N Engl J Med 2008, 358:188-190.
26. Druce L.A., Thorpe C.M., Wilton A. Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shock. Med Hypotheses 2008, 70:56-60.
27. Keh D., Sprung C.L. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 2004, 32:S527-S533.
28. Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341-348.
29. Hebbar K.B., Stockwell J.A., Fortenberry J.D. Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children. Intensive Care Med 2011, 37:518-524.